182 related articles for article (PubMed ID: 20388507)
1. Neuromedin B receptors regulate EGF receptor tyrosine phosphorylation in lung cancer cells.
Moody TW; Berna MJ; Mantey S; Sancho V; Ridnour L; Wink DA; Chan D; Giaccone G; Jensen RT
Eur J Pharmacol; 2010 Jul; 637(1-3):38-45. PubMed ID: 20388507
[TBL] [Abstract][Full Text] [Related]
2. Bombesin receptor subtype-3 agonists stimulate the growth of lung cancer cells and increase EGF receptor tyrosine phosphorylation.
Moody TW; Sancho V; di Florio A; Nuche-Berenguer B; Mantey S; Jensen RT
Peptides; 2011 Aug; 32(8):1677-84. PubMed ID: 21712056
[TBL] [Abstract][Full Text] [Related]
3. SR48692 inhibits non-small cell lung cancer proliferation in an EGF receptor-dependent manner.
Moody TW; Chan DC; Mantey SA; Moreno P; Jensen RT
Life Sci; 2014 Mar; 100(1):25-34. PubMed ID: 24496038
[TBL] [Abstract][Full Text] [Related]
4. Endothelin causes transactivation of the EGFR and HER2 in non-small cell lung cancer cells.
Moody TW; Ramos-Alvarez I; Moreno P; Mantey SA; Ridnour L; Wink D; Jensen RT
Peptides; 2017 Apr; 90():90-99. PubMed ID: 28153500
[TBL] [Abstract][Full Text] [Related]
5. Neuromedin B receptor activation causes tyrosine phosphorylation of p125FAK by a phospholipase C independent mechanism which requires p21rho and integrity of the actin cytoskeleton.
Tsuda T; Kusui T; Jensen RT
Biochemistry; 1997 Dec; 36(51):16328-37. PubMed ID: 9405068
[TBL] [Abstract][Full Text] [Related]
6. Pituitary adenylate cyclase-activating polypeptide causes tyrosine phosphorylation of the epidermal growth factor receptor in lung cancer cells.
Moody TW; Osefo N; Nuche-Berenguer B; Ridnour L; Wink D; Jensen RT
J Pharmacol Exp Ther; 2012 Jun; 341(3):873-81. PubMed ID: 22389426
[TBL] [Abstract][Full Text] [Related]
7. Evidence for autocrine actions of neuromedin B and gastrin-releasing peptide in non-small cell lung cancer.
Siegfried JM; Krishnamachary N; Gaither Davis A; Gubish C; Hunt JD; Shriver SP
Pulm Pharmacol Ther; 1999; 12(5):291-302. PubMed ID: 10545285
[TBL] [Abstract][Full Text] [Related]
8. Gastrin-releasing peptide receptor mediates activation of the epidermal growth factor receptor in lung cancer cells.
Thomas SM; Grandis JR; Wentzel AL; Gooding WE; Lui VW; Siegfried JM
Neoplasia; 2005 Apr; 7(4):426-31. PubMed ID: 15967120
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity to gefitinib (Iressa, ZD1839) in non-small cell lung cancer cell lines correlates with dependence on the epidermal growth factor (EGF) receptor/extracellular signal-regulated kinase 1/2 and EGF receptor/Akt pathway for proliferation.
Ono M; Hirata A; Kometani T; Miyagawa M; Ueda S; Kinoshita H; Fujii T; Kuwano M
Mol Cancer Ther; 2004 Apr; 3(4):465-72. PubMed ID: 15078990
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor receptor transactivation by angiotensin II requires reactive oxygen species in vascular smooth muscle cells.
Ushio-Fukai M; Griendling KK; Becker PL; Hilenski L; Halleran S; Alexander RW
Arterioscler Thromb Vasc Biol; 2001 Apr; 21(4):489-95. PubMed ID: 11304462
[TBL] [Abstract][Full Text] [Related]
11. Neurotensin receptors regulate transactivation of the EGFR and HER2 in a reactive oxygen species-dependent manner.
Moody TW; Lee L; Ramos-Alvarez I; Jensen RT
Eur J Pharmacol; 2019 Dec; 865():172735. PubMed ID: 31614143
[TBL] [Abstract][Full Text] [Related]
12. CI-988 Inhibits EGFR Transactivation and Proliferation Caused by Addition of CCK/Gastrin to Lung Cancer Cells.
Moody TW; Nuche-Berenguer B; Moreno P; Jensen RT
J Mol Neurosci; 2015 Jul; 56(3):663-72. PubMed ID: 25761747
[TBL] [Abstract][Full Text] [Related]
13. The transactivated epidermal growth factor receptor recruits Pyk2 to regulate Src kinase activity.
Schauwienold D; Sastre AP; Genzel N; Schaefer M; Reusch HP
J Biol Chem; 2008 Oct; 283(41):27748-27756. PubMed ID: 18667434
[TBL] [Abstract][Full Text] [Related]
14. Autocrine effects of neuromedin B stimulate the proliferation of rat primary osteoblasts.
Saito H; Nakamachi T; Inoue K; Ikeda R; Kitamura K; Minamino N; Shioda S; Miyata A
J Endocrinol; 2013 May; 217(2):141-50. PubMed ID: 23428580
[TBL] [Abstract][Full Text] [Related]
15. Adding of neurotensin to non-small cell lung cancer cells increases tyrosine phosphorylation of HER3.
Moody TW; Ramos-Alvarez I; Jensen RT
Peptides; 2022 Oct; 156():170858. PubMed ID: 35932909
[TBL] [Abstract][Full Text] [Related]
16. Bombesin receptor structure and expression in human lung carcinoma cell lines.
Fathi Z; Way JW; Corjay MH; Viallet J; Sausville EA; Battey JF
J Cell Biochem Suppl; 1996; 24():237-46. PubMed ID: 8806106
[TBL] [Abstract][Full Text] [Related]
17. Correlation of expression of bombesin-like peptides and receptors with growth inhibition by an anti-bombesin antibody in small-cell lung cancer cell lines.
Yang HK; Scott FM; Trepel JB; Battey JF; Johnson BE; Kelley MJ
Lung Cancer; 1998 Sep; 21(3):165-75. PubMed ID: 9857994
[TBL] [Abstract][Full Text] [Related]
18. Gastrin-releasing peptide activates Akt through the epidermal growth factor receptor pathway and abrogates the effect of gefitinib.
Liu X; Carlisle DL; Swick MC; Gaither-Davis A; Grandis JR; Siegfried JM
Exp Cell Res; 2007 Apr; 313(7):1361-72. PubMed ID: 17349623
[TBL] [Abstract][Full Text] [Related]
19. c-Jun N-terminal kinase activation by hydrogen peroxide in endothelial cells involves SRC-dependent epidermal growth factor receptor transactivation.
Chen K; Vita JA; Berk BC; Keaney JF
J Biol Chem; 2001 May; 276(19):16045-50. PubMed ID: 11278982
[TBL] [Abstract][Full Text] [Related]
20. Gastrointestinal hormones stimulate growth of Foregut Neuroendocrine Tumors by transactivating the EGF receptor.
Di Florio A; Sancho V; Moreno P; Delle Fave G; Jensen RT
Biochim Biophys Acta; 2013 Mar; 1833(3):573-82. PubMed ID: 23220008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
